AVAH
Aveanna Healthcare Holdings, Inc. Health Care Services-Home Health Care Services Russell 3000
$13.16Close
$2.8BMarket cap
$6.22 – $14.3852-week range
Nov 12, 2026Next report · before the open
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 94 · stronger than 94% of stocks over 12 months
- Volume drying up last 10 days 38% under the 50-day average
- Earnings growing EPS +40% year on year
Cautions
- Results soon Nov 12, 2026, in 11 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
8%
1wk
down 1.6%
price change
1mo
up 6.0%
price change
12-month return
up 41%
market up 11% ·
its own up 23%
F-score
8 / 9
Exceptional
Altman Z″
-0.46
Elevated risk
P/E
12339.1×
price / earnings
PEG
—
P/E / EPS growth
P/B
14.3×
price / book
Earnings yield
up 6.6%
EBIT / enterprise value
Cheaper than
50%
of the market · around average
Revenue growth
up 20%
year on year
EPS growth
up 40%
latest quarter · -605 pts
Sales growth
up 14%
latest quarter · -2 pts
ROE
0%
return on equity
Free cash margin
up 5%
$125.9M FCF
D/E
6.62
long-term debt / equity
Net debt / EBITDA
4.1×
Interest cover
1.8×EBIT / interest
Piotroski tests
- issued more shares
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
- assets working harder
Repair signals
- Gross margin 31.4% → 33.3%
Trade setup
ATR%
3.2%
$0.42 a day · 2×ATR $12.31
RS
94 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.5×
vs 50-day average
Up/down volume
1.08
50 sessions
Implied move
—
no option chain · report Nov 12, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Interest is covered, but thinly Earnings before interest cover the interest bill 1.8 times, leaving little room if profits fall.
- Heavily indebted Net debt is 4.1 times EBITDA — roughly 4 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Shareholders diluted The share count rose 9.2% over the year, from 193m to 211m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 13, 2026
Results reaction
Aug 13, 2026+36% vs market2 sessions after results
Financials
- Gross 33%
- Net 0%
- Free cash 5%
- Cash
- Long-term debt
| FY2020Jan 2, 2021 | FY2021Jan 1, 2022 | FY2022Dec 31, 2022 | FY2023Dec 30, 2023 | FY2024Dec 28, 2024 | FY2025Jan 3, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.7B | $1.8B | $1.9B | $2.0B | $2.4B |
| Gross margin | 30% | 32% | 31% | 31% | 31% | 33% |
| Operating income | -$3.5M | -$36.1M | -$642.3M | $8.1M | $139.8M | $256.5M |
| Net income | -$57.0M | -$117.0M | -$662.0M | -$134,524 | -$10,929 | $225,034 |
| Net margin | -4% | -7% | -37% | -0% | -0% | 0% |
| Earnings per share | — | -$685.97 | -$3.57 | -$0.00 | -$0.00 | $0.00 |
| Free cash flow | $101.4M | -$27.3M | -$48.4M | $22.7M | $32.6M | $125.9M |
| Free cash margin | 7% | -2% | -3% | 1% | 2% | 5% |
| Cash | $137.3M | $30.5M | $19.2M | $43.9M | $84.3M | $193.3M |
| Long-term debt | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
| Shareholders' equity | $265.0M | $635.8M | -$6.3M | -$129.6M | -$123.6M | $194.5M |
| Shares outstanding | 141.93m | 184.73m | 188.86m | 190.73m | 193.23m | 211m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 13, 2026 | Quarterly ↗ | Jul 4, 2026 | 40d |
| May 14, 2026 | Quarterly ↗ | Apr 4, 2026 | 40d |
| Mar 19, 2026 | Annual ↗ | Jan 3, 2026 | 75d |
| Nov 6, 2025 | Quarterly ↗ | Sep 27, 2025 | 40d |
| Aug 7, 2025 | Quarterly ↗ | Jun 28, 2025 | 40d |
| May 8, 2025 | Quarterly ↗ | Mar 29, 2025 | 40d |
| Mar 13, 2025 | Annual ↗ | Dec 28, 2024 | 75d |
| Nov 7, 2024 | Quarterly ↗ | Sep 28, 2024 | 40d |
| Aug 8, 2024 | Quarterly ↗ | Jun 29, 2024 | 40d |
| May 9, 2024 | Quarterly ↗ | Mar 30, 2024 | 40d |
| Mar 14, 2024 | Annual ↗ | Dec 30, 2023 | 75d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 2, 2026 | Director or officer change ↗ |
| Aug 24, 2026 | Other events ↗ |
| Aug 13, 2026 | Regulation FD ↗ |
| Aug 13, 2026 | Results · Regulation FD ↗ |
| Aug 7, 2026 | Director or officer change ↗ |
| Jun 2, 2026 | Other events ↗ |
| May 29, 2026 | Shareholder vote ↗ |
| May 28, 2026 | Other events ↗ |
| May 15, 2026 | Regulation FD ↗ |
| May 14, 2026 | Results · Regulation FD ↗ |
| Mar 20, 2026 | Regulation FD ↗ |
| Mar 19, 2026 | Results · Regulation FD ↗ |